Inventor · disambiguated record
Benjamin Paul Whittaker
Also filed as: WHITTAKER BENJAMIN · WHITTAKER BENJAMIN PAUL
9 granted patents·4 pending applications·23 citations·filing 2016–2024
83Inventor score
Top patents by PatentIndex Score
13 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0292US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0392US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0486US11926625B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 12, 2024·1 cites·17 claims
- 0585US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 0682US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0775US12466841B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2023·Granted Nov 11, 2025·0 cites·24 claims
- 0872US2024199603A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2024·Application pending·0 cites
- 0970US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 1067US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1166US12071442B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2022·Granted Aug 27, 2024·0 cites·19 claims
- 1260US2024150321A1Pyrazolylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1355US12252488B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 18, 2025·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Benjamin Paul Whittaker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →